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Hypothesis/Commentary
Cancer Disparities: Unmet Challenges in the Elimination
of Disparities
Sarah Gehlert and Graham A. Colditz
Abstract
Background: The first 20 years of publication of Cancer Epidemiology, Biomarkers & Prevention occurred
during a period of increased attention to health disparities and advances in knowledge about their
determinants. Yet, despite clear documentation of disparities and advanced understanding of determinants,
we have made little headway in reducing disparities at the population level. Multilevel models, such as one
produced by the Centers for Population Health and Health Disparities (CPHHD), hold promise for under-
standing the complex determinants of cancer disparities and their interactions as well as translating scientific
discoveries into solutions. The CPHHDmodelmaps across a range of scientific disciplines, from the biological
to the social, each with its own disciplinary language and methods. The ability to work effectively across
disciplinary boundaries is essential to framing comprehensive solutions.
Methods: After briefly characterizing the current state of knowledge about health disparities, we outline
three major challenges faced by disparities researchers and practitioners and offer suggestions for addressing
these challenges.
Results: These challenges are how to consider race and ethnicity in disparities research, how best to
translate discoveries into public health solutions to cancer disparities, and how to create a research
environment that supports the successful execution of multilevel research.
Conclusions: Attention to all three of the challenges outlined above is urgently needed to advance our
efforts to eliminate cancer disparities.
Impact: Addressing the challenges outlined above will help to eliminate disparities in the future. Cancer
Epidemiol Biomarkers Prev; 20(9); 1809–14. 2011 AACR.
We are the hollow men, we are the stuffed men, leaning
together, headpiece filled with straw. Alas!
–T.S. Eliot (1925)
The first 20 years of publication of Cancer Epidemiology,
Biomarkers & Prevention occurred during a period of
increased attention to health disparities and advances
in knowledge about their determinants. Yet, while some
questions have been answered, new, arguably more
sophisticated and complex questions have come to light.
Consequently, many challenges to our ability to amelio-
rate cancer and other disparities remain. After briefly
characterizing the current state of knowledge about heath
disparities in the United States, we comment on themajor
challenges facing health disparities researchers and prac-
titioners today.
Although the collection of detailed information on race
and ethnicity was a goal of Surveillance, Epidemiology,
and End Results (SEER) since its inception in 1973, it was
not until the 1990 census that mortality data by ethnic
group for cancer and other major diseases were available
for all 50 states. This more detailed information drew
public attention to racial and ethnic health disparities,
ultimately leading to a number of federal initiatives
aimed at addressing those disparities. President Clinton’s
1998 Racial and Ethnic Health Disparities Initiative (1) set
an ambitious goal of eliminating racial and ethnic dis-
parities by 2010, and $400 million from Clinton’s
balanced budget plan was devoted to disparities
research. The U.S. Department of Health and Human
Services took leadership of the effort and set eliminating
health disparities as 1 of the 2 overarching goals of
Healthy People 2010 (2). In 2000, the National Center
for Minority Health and Health Disparities was estab-
lished under the Minority Health and Health Disparities
Research and Education Act (3).
In 2003, the National Cancer Institute (NCI), in concert
with the National Institute for Environmental Health
Sciences, and the National Institute of Aging devoted
$60.5 million to the Centers for Population Health and
Health Disparities Initiative, which is now in its second
cycle of funding. Five of the 8 centers during the first
funding cycle focused on cancer disparities. In the second
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cycle, NCI has partnered with the National Heart Lung
and Blood Institute, and 5 of the 10 funded centers focus
on cancer disparities.
Despite increased attention to health disparities and
advances in our understanding of their determinants, we
have made little headway in reducing disparities at the
population level. Disparities in cancer, cardiovascular
disease, obesity, diabetes, and other chronic diseases
have been documented extensively in the public health
record. These disparities can be summed as the gap in life
expectancy between urban black males and Asian males
(15.4 years; ref. 4). Yet, despite clear documentation and
elegant quantification of disparities, our population
health response has been limited in its effectiveness to
eliminate disparities. Does this academic and public
health services response reflect on us collectively as a
headpiece filled with straw?
Multilevel Models of Cancer Disparities
Investigators from the Centers for Population Health
and Health Disparities (CPHHD), representing a range of
populations and cancers, collaborated to define a model
that would help frame research and speed understanding
across disciplines and between providers, communities,
and public health agents (5). The conceptual framework
for cancer disparities was developed by Warnecke and
colleagues (including Dr. Gehlert) to address the ques-
tion, "Howdoes population risk relate to individual risk?"
(5), drawing from their own work as part of the CPHHD
and from the work of other leaders in the field (6–8) to
address this question from a multilevel perspective. The
major implication of the model is that multiple levels of
influence from the microbiological to the societal interact
in complex ways to produce cancer disparities. The
framework for analysis of population health and health
disparities includes 3 primary levels of determinants,
namely, distal, intermediate, and proximal.
Distal determinants include population-level social
conditions such as variation in rates of disease or pov-
erty. Their roots are embedded in shared social norms
about health or social practices and socioeconomic
disadvantage.
Intermediate determinants include the immediate
social and physical contexts and social relationships in
which the distal effects are experienced, such as the
community or neighborhood. The social context includes
the extent of residential segregation and opportunities for
social interaction to redress the effect of the distal factors.
Also included is the accessibility of local health care
resources to the public, availability of transportation,
and quality of the built environment. The intermediate
determinants are the links through which the environ-
ment affects individual demographic factors as well as
biologic responses that compose the proximal determi-
nants. Demographic factors refer to both contexts and
individuals and in the model can have independent
effects.
Proximal determinants include biological and genetic
factors such as ancestry and family history of disease.
They also include individual-level factors such as demo-
graphics and health behavior.
Implications for Cancer Disparities Research
Research has evolved from merely describing dispa-
rities to refining approaches that allow us to mount
appropriate public health responses. The multiple levels
of investigation suggested by the CPHHD model map
across a range of scientific disciplines, from the biologi-
cal/genetic to the social, each potentially bringing its own
siloed approach and blinkered way of conducting and
reporting research. This occurs in part because of our
limited capacity to promote and sustain communication
across disciplinary boundaries, thus impeding our pro-
gress in understanding and acting to eliminate dispari-
ties. Extensive study of the genome over the past decade,
for example, has advanced our understanding of the
carcinogenic process, yet limited understanding of the
interplay between genome and environment in relation to
disease risk or outcomes has slowed our translation to
treatment and prevention. Understanding the genome
and its role in behaviors has a great deal of potential. We
note, for example, some progress on nicotine addiction, in
which genetic predisposition may vary by single-nucleo-
tide polymorphisms that track with genetic origins of
populations (9, 10) and have important implications for
addiction, and cessation from use of tobacco products,
hence instantly important for the inordinate health bur-
den caused by tobacco.
A clear definition of models to advance our insights
into the causes of cancer disparities and frame compre-
hensive programs and solutions to them depends on our
ability to work transdisciplinarily in a way that trans-
cends disciplinary boundaries. Although transdisciplin-
ary approaches to science are in their infancy, they
potentially can help us to capture the complexity of
phenomena such as cancer disparities by virtue of pro-
viding a blueprint for how to talk across disciplines and
to translate lessons from animal models to humans to
whole populations. The ability to communicate across
disciplines will allow us to more fully capture the com-
plex ways in which the determinants at the distal, inter-
mediate, and proximal levels interact with one another to
fuel cancer disparities.
In addition to their role in the design of cancer dis-
parities research, it is also important to consider the
implication ofmultilevelmodels for the design and action
for elimination of disparities. Research studies should
always be designed with an eye toward informing sub-
sequent implementation, as well as ensuring sustainable
change after an intervention is completed. As an example,
translating the discoveries of variation in nicotine addic-
tion mentioned earlier (9) into public health interventions
requires translation and implementation at a number of
junctures. First, affordable clinical tests to determine
Gehlert and Colditz
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propensity for addiction must be developed, tested, and
introduced into clinical practice. Then, smoking cessation
interventions tailored to nicotine addiction subgroups
must be developed, tested, and introduced into provider
systems in a way that heightens the likelihood of their
acceptance and use. Finally, some means of sustaining
their use through time is needed, perhaps through dis-
seminating information about their utility and effective-
ness to providers and the general public. It is reasonable
to assume that the extent to which "implementers" along
the chain are familiar with the work of others who
preceded them will in part determine the success of their
own efforts. Familiarity with discoveries of variation in
nicotine addiction, for example, will allow primary care
providers to better explain the virtues of smoking cessa-
tion interventions to their patients. Likewise, social mar-
keters have to know the results of effectiveness trials, and
so on.
Current Challenges to Cancer Disparities
Research
A number of challenges remain in our ability to under-
stand the determinants of health disparities and success-
fully translate that understanding into successful
interventions to decrease cancer disparities at the popu-
lation level. The 3 major challenges are how to consider
race and ethnicity in disparities research (i.e., what is the
place of race and ethnicity in health disparities research),
how best to translate discoveries into public health solu-
tions to cancer disparities, and how to create a research
environment that allows for the successful execution of
multilevel research.
Race and Ethnicity in Cancer Disparities
Research
Since the time of Clinton’s 1998 Racial and Ethnic
Health Disparities Act, there has been a tendency to
conflate health disparities research with minority health
research. More often than not, group comparisons are
done by race/ethnicity, oftenwithout a strong conceptual
basis for doing so. We argue that this has resulted in an
emphasis on race and ethnicity as determinants of cancer
disparities over socioeconomic status or other factors.
This has occurred despite ample and growing evidence
of the effect of social determinants on disparities and
problems with defining and measuring race (11). Gehlert
and colleagues, for example, found that social measures
such as exposure to crime and social isolation were
significantly associated with lack of estrogen and pro-
gesterone receptor expression among African American
women newly diagnosed with breast cancer in Chicago
(12).
Meara and colleagues discovered that the picture for
gains in life expectancy through time by race and gender
changes markedly when groups are again divided into
low and high levels of education (13). The authors found,
for example, that life expectancy at age 25 years declined
for both African American and white women with low
levels of education whereas it increased for women with
high levels of education. In other words, the addition of a
social factor changed the way that race operated in life
expectancy gains.
Many authors have questioned the utility of race in
research (14). Without repeating those arguments, we
note that self-reported race/ethnicity, the norm in health
disparities research, does not always match genotype (15,
16). Thus, racial and ethnic groups based on self-report
may not accurately allow the comparisons that investi-
gators intend to make if self-reported race was intended
to be a proxy for genotype. This could affect the results of
their work and the conclusions drawn from those results,
rendering the interventions, practices, and policies
derived less suitable and effective.
The elimination of cancer disparities relies on a much
more nuanced understanding of what underlies those
disparities, as well as the complex ways in which factors
at multiple levels of influence interact with one another,
than tacitly basing research design on cross-race compar-
isons. Race/ethnicity is now more likely to be measured
in public health statistics than education or other social
variables. Comparing first by race/ethnicity presumes
significant biological differences that may not be perti-
nent to the cancer disparities issue under investigation
and may draw attention away from other, more signifi-
cant, determinants. Likewise, comparisons across racial
and ethnic groups that rely solely on self-report of race/
ethnicity may produce error.
Translating Discoveries into Effective
Interventions
From the outset of training to early narrowing of
research focus and the successful launching of academic
careers, our research system is focused on fostering
excellence, scientific discoveries, and career advance-
ment, usually tied to publication and funding records.
This system then rewards isolated researchers who make
noteworthy "discoveries." Application or translation of
discovery to impact or implementation is of far lower
stature.
Although favoring discovery over translation and
application of findings doubtless has launched a high
number of successful careers, it has had less of an impact
on the nation’s health disparities. Arguably impacting
disparities that are known to have multilevel determi-
nants not only requires an appreciation of the work of
translational science and scientists but also requires that
scientists at each stage of the continuum from discovery
to translation have the opportunity and skills to commu-
nicate with one another. In addition, it is important to
recognize that, for maximum effectiveness, this commu-
nication must be bidirectional. Research ideas must move
not just from bench to population but also from popula-
tion back to bench.
Unmet Challenges in Cancer Disparities
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Moving from discovery to application brings society
the full return on our collective investment in research.
For example, in 2008, biomedical research expenditures
in the United States exceeded $100 billion on health-
related research (17, 18). Only a small fraction of the 30
billion NIH components was expended on prevention
research (19, 20), that is, the direct and immediate appli-
cation of effective intervention strategies to benefit the
public’s health (p. 93; ref. 21). Despite this low priority,
the NIH maintains an active program in "dissemination"
research, albeit with an extremely low level of funding.
Across all funding sources through 2008—federal and
foundations—spending on health services research,mod-
els of care, and service innovations, represented only
about 1.5% of biomedical research funding (22). With
few resources, little attention is paid to the translation of
scientific discovery to effective programs.
Executing Successful Multilevel Research
Executing successful multilevel research depends on
the ability to visualize the multiple influences on cancer
and cancer disparities and understand the complex ways
in which they interact with one another to produce worse
outcomes for some groups than others. This can be done
neither by a single investigator nor by a single discipline.
Yet, despite a growing emphasis on transdisciplinary
research, few research teams have achieved transdisci-
plinary functioning.
Operating transdisciplinarily is not intuitive and
requires training and education as well as support. For
the most part, disciplinary scholars continue to be trained
primarily in the language and methods of their own
individual fields of training. Although scattered trans-
disciplinary training programs exist, they have not been
systematically integrated into formal educational curri-
cula. This lack of systematic training in transdisciplinary
science reinforces the siloed nature of research and hin-
ders the transfer of knowledge across disciplines.
This lack of attention to the transdisciplinary training
of students is mirrored in the governance of faculty by
institutional administrators. In general, the science of
transdisciplinary research has been inadequately recog-
nized within academia for its contribution to clinical and
public health outcomes. Appointment and promotion
committees traditionally focus on new advances in
understanding and research that "changes the field,"
ascribing a lower status to the application of scientific
advances to improve health care delivery and well-being
of the community. Appointment and promotion guide-
lines that emphasize the contribution of transdisciplinary
research and the time required for integrating research
with practice will help set the standard for this aspect of
research and practice to be valued and rewarded. Alter-
natively, a metric that captures the public health impact
associated with each activity (research, teaching, and
service) may have added benefits of creating demand
for investment of time and funding in higher-yielding
research and allowing comparison of the relative value of
transdisciplinary research.
Just as structural changes are needed to stimulate
lasting behavior change by individuals, we might also
consider such structural changes as priorities within the
academy to provide incentives for increasing implemen-
tation of evidence-based practices to reduce health dis-
parities. Like other areas of modern public health
research, integrating transdisciplinary research into prac-
tice also requires substantial teamwork and time, in part
through building and sustaining community relation-
ships. These are aspects of population health sciences
that may be harder to quantify in a way that can be
consistently measured as contributions by individual
faculty members. Metrics that can be reported for promo-
tions will again be a necessary step to valuing this aspect
of public health practice.
To engage community participants in research, which
truly is necessary for translating discovery into public
health practice, it is essential for academic centers to have
a sustained presence in communities. These may be
geographic communities, but they may also include vir-
tual communities, in the case of rare or uncommon
conditions. They also may involve working with com-
munity organizations rather than directly with indivi-
duals experiencing health problems. This occurs in the
case of individuals who do not identify as being part of a
group, such as mothers of severely overweight children,
substance abusers, or women experiencing intimate part-
ner violence. Few sustained community and academic
partnerships have succeeded, reflecting in part the expec-
tation as noted by Richmond in 1969 (23) that with NIH
funding clinical research centers, they would focus
inward and ignore the source population from which
the participants were drawn, leading to medical research
disconnected from the community and broader society.
From the community perspective, a major challenge
includes the accountability structure for public health
and clinical research matching community-defined prio-
rities for the elimination of disparities, if those priorities
can be articulated. Furthermore, the coordination of com-
munity assessment and delivery of activities is often
fragmented because of exigencies of funding streams,
yet at the community level, an integrated implementation
makes most sense. Achieving integration may require a
more coordinated set of activities from academic
partners collaborating in linking research with imple-
mentation. In the worst (but perhaps most typical) sce-
nario, researchers do not coordinate their efforts to
engage community partners, leaving communities over-
whelmed with requests and conflicting requests. Cancer
centers and academic–community networks can play an
important role in coordinating these relationships and
ensuring that engagement with communities is appro-
priate and effective.
Community-based participatory research (CBPR)
methods offer a means of improving engagement
with communities and enhancing the relevance and
Gehlert and Colditz
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effectiveness of public health interventions (24–26). CBPR
relies on a collaborative partnership that equitably and
actively involves community partners in all aspects of the
research process (27–30). Effective CBPR partnerships
build expertise and capacity in the community for
research and prevention and thus have significant poten-
tial to make a sustainable impact.
Accountability is challenging when we set forth long-
term goals for community needs. Are our public health
schools, our medical schools, or our local health depart-
ments and administrative structures held accountable for
meeting the community needs? If yes, by whom? If no,
where does this responsibility rest?
Discussion
The very fact that much has been accomplished over
the past 20 years to increase our understanding of cancer
disparities makes moving forward to ameliorate those
disparities even more of an imperative. Reorientation of
research trajectories, rewards, and institutional policies
and commitment will be necessary to adequately address
the challenges to ameliorating those disparities. We hope
that documenting the need for multilevel approaches to
research and implementation and providing some idea of
what it will take to implement those approaches will
help to turn the straw-headedness of the past into effi-
cient brain functioning in the future. Our efforts are
aimed at funding bodies and research groups to reorient
their plans and strategies to frame research and imple-
mentation from conceptualization to data collection,
analysis, and action so that it is readily translated to
full-scale implementation that addresses simultaneously
the many levels of change that will be necessary to
eliminate disparities. Likewise, we challenge institutions
of learning to adapt their curricular structures to provide
transdisciplinary research education as early in the edu-
cational process as possible. We emphasize the value of
working in partnership with communities, defined in
more nuanced ways than has always been the case in
the past. In this way, we can traverse the path from
discovery to public health approaches to eliminating
cancer disparities.
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